|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02370 REDCO HEALTHY
Nominal 
0.850 0.000 (0.000%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 400,535 | -4.552% | 419,635 | 449,273 | 437,113 | 354,327 |
| Cost of Sales | (303,628) | -0.842% | (306,206) | (323,601) | (294,239) | (238,558) |
| Gross Profit | 96,907 | -14.566% | 113,429 | 125,672 | 142,874 | 115,769 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | (6,013) | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (21,508) | -67.229% | (65,632) | (63,389) | (69,151) | (3,487) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 179 | -89.824% | 1,759 | 1,580 | 1,055 | 2,145 | |
| Profit / (Loss) before Taxation | (4,195) | -62.724% | (11,254) | 6,934 | 16,037 | 59,271 | |
| Taxation | (5,058) | -42.757% | (8,836) | (6,667) | (6,084) | (19,138) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (8,286) | -0.624% | (8,338) | (10,250) | (6,764) | (7,993) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (17,539) | -38.304% | (28,428) | (9,983) | 3,189 | 32,140 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 139 | -- | (234) | 615 | 1,036 | 418 |
| Depreciation & Amortisation | 11,980 | -10.550% | 13,393 | 15,579 | 11,725 | 10,577 |
| Directors' Emoluments | -- | -- | 4,473 | 3,406 | 2,314 | 134 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified (Modified Report) | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -8.770 | -38.283% | -14.210 | -4.990 | 1.700 | 21.430 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.100) | 0.406 | (0.167) | 0.234 |
| NBV per share ($) | 1.219 | -- | 1.314 | 1.456 | 1.504 | -- |
| Remarks: | Real time quote last updated: 10/04/2026 16:15 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -17,539 |
| %Change | -38.304% |
| EPS / (LPS) | RMB -0.088 |
| NBV Per Share (¥) | RMB 1.219 |